Silence Therapeutics stockSLN
Silence Therapeutics trades at $19.72, 0.7% below its 52-week high (Oct 26, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +224.3% year to date, +216.0% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 17, 2026.
Ratings, candles, signals and the screener for SLN — after you log in
Open the terminalFrequently asked questions about Silence Therapeutics
What is the Silence Therapeutics stock price?
At the close on Nov 5, 2026: $19.72 (−0.40% on the day). 52-week high: $19.86 on Oct 26, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Silence Therapeutics report earnings?
The next quarterly report is on Nov 17, 2026. Last quarter, earnings per share changed +53% year over year, revenue −100%.
Does Silence Therapeutics pay dividends?
No, Silence Therapeutics does not pay dividends.
Where does Silence Therapeutics trade and how to buy it?
Ticker SLN, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Silence Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for SLN are in the terminal after you log in.